A Pilot Study of the Relaxation Response Resiliency Program for Von Hippel-Lindau Disease
Active, Not Recruiting Not Applicable NCT05737602
Study Description
Promoting Stress Management and Resilience Among Individuals With Von Hippel-Lindau Disease
Study Details
- Registry ID:
- NCT05737602
- Conditions:
- Von Hippel-Lindau Disease, Genetic Disorder
- Phase:
- Not Applicable
- Target Enrollment:
- 40 participants
- Start Date:
- Age Range:
- 18–999 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.